3G7V image
Deposition Date 2009-02-10
Release Date 2009-06-23
Last Version Date 2023-09-06
Entry Detail
PDB ID:
3G7V
Title:
Islet Amyloid Polypeptide (IAPP or Amylin) fused to Maltose Binding Protein
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 83333)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.86 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Maltose-binding periplasmic protein, Islet amyloid polypeptide fusion protein
Gene (Uniprot):malE, IAPP
Chain IDs:A, B, C, D
Chain Length:408
Number of Molecules:4
Biological Source:Escherichia coli, Homo sapiens
Peptide-like Molecules
PRD_900001
Primary Citation
Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process
Protein Sci. 18 1521 1530 (2009)
PMID: 19475663 DOI: 10.1002/pro.145

Abstact

Islet Amyloid Polypeptide (IAPP or amylin) is a peptide hormone produced and stored in the beta-islet cells of the pancreas along with insulin. IAPP readily forms amyloid fibrils in vitro, and the deposition of fibrillar IAPP has been correlated with the pathology of type II diabetes. The mechanism of the conversion that IAPP undergoes from soluble to fibrillar forms has been unclear. By chaperoning IAPP through fusion to maltose binding protein, we find that IAPP can adopt a alpha-helical structure at residues 8-18 and 22-27 and that molecules of IAPP dimerize. Mutational analysis suggests that this dimerization is on the pathway to fibrillation. The structure suggests how IAPP may heterodimerize with insulin, which we confirmed by protein crosslinking. Taken together, these experiments suggest the helical dimerization of IAPP accelerates fibril formation and that insulin impedes fibrillation by blocking the IAPP dimerization interface.

Legend

Protein

Chemical

Disease

Primary Citation of related structures